Epoetin delta reduces oxidative stress in primary human renal tubular cells

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  D'Haese, Patrick C ^a,b   De Beuf, Annelies ^a   Hou, Xiang Hua ^a   Verhulst, Anja ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 1; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; CYTOGLOBIN; DIPEPTIDYL PEPTIDASE IV; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLUCOSE OXIDASE; HEME OXYGENASE 1; MESSENGER RNA; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; GLOBIN; METALLOPROTEINASE; PROTECTIVE AGENT;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TUBULE CELL; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PROCESSING; RENAL PROTECTION; UPREGULATION; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOLOGY;

ANTIGENS, CD26; CELLS, CULTURED; EPITHELIAL CELLS; EPOETIN ALFA; ERYTHROPOIETIN, RECOMBINANT; GENE EXPRESSION REGULATION; GLOBINS; GLUCOSE OXIDASE; HUMANS; KIDNEY TUBULES, PROXIMAL; METALLOENDOPEPTIDASES; OXIDATIVE STRESS; PROTECTIVE AGENTS; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER;

EID: 77952526531     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/395785     Document Type: Article

References (43)

1. Dryden G. W. Jr., Deaciuc I., Arteel G., McClain C. J., Clinical implications of oxidative stress and antioxidant therapy Current Gastroenterology Reports 2005 7 4 308 316
2. Forsberg L., de Faire U., Morgenstern R., Oxidative stress, human genetic variation, and disease Archives of Biochemistry and Biophysics 2001 389 1 84 93
3. Lee J.-C., Kim J., Park J.-K., Chung G.-H., Jang Y.-S., The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis Experimental Cell Research 2003 291 2 386 397
4. Rice-Evans C. A., Miller N. J., Bolwell P. G., Bramley P. M., Pridham J. B., The relative antioxidant activities of plant-derived polyphenolic flavonoids Free Radical Research 1995 22 4 375 383
5. Katavetin P., Tungsanga K., Eiam-Ong S., Nangaku M., Antioxidative effects of erythropoietin Kidney International 2007 107 S10 S15
6. Bahlmann F. H., Fliser D., Erythropoietin and renoprotection Current Opinion in Nephrology and Hypertension 2009 18 1 15 20
7. Helbert M. J. F., Dauwe S. E. H., Van der Biest I., Nouwen E. J., De Broe M. E., Immunodissection of the human proximal nephron: flow sorting of S1S2SS3, S1S2 and S3 proximal tubular cells Kidney International 1997 52 2 414 428
8. Helbert M. J. F., Dauwe S. E. H., De Broe M. E., Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system Kidney International 2001 59 2 554 564
9. Gibson-D'Ambrosio R. E., Samuel M., Chang C. C., Trosko J. E., D'Ambrosio S. M., Characteristics of long-term human epithelial cell cultures derived from normal human fetal kidney In Vitro Cellular Developmental Biology 1987 23 4 279 287
10. Barbouti A., Doulias P.-T., Nousis L., Tenopoulou M., Galaris D., DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H 2 O 2 Free Radical Biology and Medicine 2002 33 5 691 702
11. Gong H., Wang W., Kwon T.-H., EPO and-MSH prevent ischemia/reperfusion- induced down-regulation of AQPs and sodium transporters in rat kidney Kidney International 2004 66 2 683 695
12. Vesey D. A., Cheung C., Pat B., Endre Z., Gob G., Johnson D. W., Erythropoietin protects against ischaemic acute renal injury Nephrology Dialysis Transplantation 2004 19 2 348 355
13. Kirkeby A., van Beek J., Nielsen J., Leist M., Helboe L., Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor Journal of Neuroscience Methods 2007 164 1 50 58
14. Li Y., Takemura G., Okada H., Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure Cardiovascular Research 2006 71 4 684 694
15. Pajonk F., Weil A., Sommer A., Suwinski R., Henke M., The erythropoietin-receptor pathway modulates survival of cancer cells Oncogene 2004 23 55 8987 8991
16. De Beuf A., Verhulst A., Helbert M., Tubular erythropoietin receptor expression mediates erythropoietin-induced renoprotection The Open Hematology Journal 2009 3 1 10
17. Kirkby K. A., Adin C. A., Products of heme oxygenase and their potential therapeutic applications American Journal of Physiology 2006 290 3 F563 F571
18. Wagner M., Cadetg P., Ruf R., Mazzucchelli L., Ferrari P., Redaelli C. A., Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts Kidney International 2003 63 4 1564 1573
19. Blydt-Hansen T. D., Katori M., Lassman C., Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury Journal of the American Society of Nephrology 2003 14 3 745 754
20. Katavetin P., Inagi R., Miyata T., Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress Biochemical and Biophysical Research Communications 2007 359 4 928 934
21. Ryter S. W., Choi A. M. K., Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy American Journal of Respiratory Cell and Molecular Biology 2009 41 3 251 260
22. Nielsen S., Frkiaer J., Marples D., Kwon T.-H., Agre P., Knepper M. A., Aquaporins in the kidney: from molecules to medicine Physiological Reviews 2002 82 1 205 244
23. Echevarra M., Muoz-Cabello A. M., Snchez-Silva R., Toledo-Aral J. J., Lpez-Barneo J., Development of cytosolic hypoxia and hypoxia-inducible factor stabilization are facilitated by aquaporin-1 expression Journal of Biological Chemistry 2007 282 41 30207 30215
24. Sharples E. J., Patel N., Brown P., Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion Journal of the American Society of Nephrology 2004 15 8 2115 2124 (Pubitemid 39031350)
25. Yang C. W., Li C., Jung J. Y., Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney The FASEB Journal 2003 17 12 1754 1755
26. Reverter D., Maskos K., Tan F., Skidgel R. A., Bode W., Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity Journal of Molecular Biology 2004 338 2 257 269
27. Deiteren K., Surpateanu G., Gilany K., The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over Biochimica et Biophysica Acta 2007 1774 2 267 277
28. Deiteren K., Hendriks D., Scharp S., Lambeir A. M., Carboxypeptidase M: multiple alliances and unknown partners Clinica Chimica Acta 2009 399 1-2 24 39
29. McGwire G. B., Becker R. P., Skidgel R. A., Carboxypeptidase M, a glycosylphosphatidylinositol-anchored protein, is localized on both the apical and basolateral domains of polarized Madin-Darby canine kidney cells Journal of Biological Chemistry 1999 274 44 31632 31640
30. Nishioka Y., Higuchi T., Sato Y., Human migrating extravillous trophoblasts express a cell surface peptidase, carboxypeptidase-M Molecular Human Reproduction 2003 9 12 799 806
31. Lambeir A.-M., Durinx C., Scharp S., De Meester I., Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Critical Reviews in Clinical Laboratory Sciences 2003 40 3 209 294
32. Lambeir A.-M., Scharp S., De Meester I., DPP4 inhibitors for diabeteswhat next? Biochemical Pharmacology 2008 76 12 1637 1643
33. Zhai W., Cardell M., De Meester I., Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia Journal of Heart and Lung Transplantation 2007 26 2 174 180
34. Jung F. J., Yang L., De Meester I., CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats Journal of Heart and Lung Transplantation 2006 25 9 1109 1116
35. Belyaev A., Zhang X., Augustyns K., Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors Journal of Medicinal Chemistry 1999 42 6 1041 1052
36. Kenny A. J., Booth A. G., George S. G., Dipeptidyl peptidase IV, a kidney brush border serine peptidase Biochemical Journal 1976 157 1 169 182
37. Fujiwara H., Higuchi T., Sato Y., Regulation of human extravillous trophoblast function by membrane-bound peptidases Biochimica et Biophysica Acta 2005 1751 1 26 32
38. Fordel E., Geuens E., Dewilde S., De Coen W., Moens L., Hypoxia/ischemia and the regulation of neuroglobin and cytoglobin expression IUBMB Life 2004 56 11-12 681 687
39. Pesce A., Bolognesi M., Bocedi A., Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family EMBO Reports 2002 3 12 1146 1151
40. Shigematsu A., Adachi Y., Matsubara J., Analyses of expression of cytoglobin by immunohistochemical studies in human tissues Hemoglobin 2008 32 3 287 296
41. Burmester T., Gerlach F., Hankeln T., Regulation and role of neuroglobin and cytoglobin under hypoxia Advances in Experimental Medicine and Biology 2007 618 169 180
42. Hodges N. J., Innocent N., Dhanda S., Graham M., Cellular protection from oxidative DNA damage by over-expression of the novel globin cytoglobin in vitro Mutagenesis 2008 23 4 293 298
43. Xu R., Harrison P. M., Chen M., Cytoglobin overexpression protects against damage-induced fibrosis Molecular Therapy 2006 13 6 1093 1100